Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-27

Clinical Trial Update: Approaches To Therapy Escalation In T2D [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating therapy escalation approaches in Type 2 Diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: LMC Diabetes & Endocrinology Ltd. | Conditions: Type2 Diabetes | Phase 4 | Status: WITHDRAWN